Seeking Alpha
Long/short equity, contrarian, short-term horizon, dividend investing
Profile| Send Message|
( followers)  

Health Management Associates (NYSE:HMA) is scheduled to release last fiscal quarter's results after the closing bell on October 24, 2011.

Overview
HMA trades an average of 3.6 million shares per day.

Health Management Associates, Inc., through its subsidiaries, engages in the operation of general acute care hospitals and other health care facilities in non-urban communities in the United States. The company was founded in 1977 and is based in Naples, Florida.

52-Week High: $11.74
52-Week Low: $6.06
Book Value: $2.61
Float Short: 4.31%

On average, 18 analysts are expecting a drop of $-0.03 in earnings per share compared to last quarter's results of $0.20. The reporting quarter's estimated mean earnings are $0.17 per share. Analyst estimates range between $0.15 and $0.19 per share.

The current trailing twelve months (ttm) P/E ratio is 12.2. The forward P/E ratio is 10.6. In the last month, the stock has increased in price 7.44%, and changing from last year at this time 13.05%. When comparing to the S&P 500, the year-to-date difference is -11.40%.

Revenue year-over-year has increased to $5.11 billion for 2010 vs. $4.56 billion for 2009. The bottom line has rising earnings year-over-year of $150.07 million for 2010 vs. $138.18 million for 2009. The company's earnings before income and taxes are rising, with an EBIT year-over-year of $490.15 million for 2010 vs. $440.89 million for 2009.

paid2trade.com revenue gross bar chart for HMA

Gross reported revenue compared to the mean estimate (rounded).

Fiscal Quarter Ending Month-Year Revenue Estimates Actual $ Difference Difference %
Jun-11 $ 1.41 B $ 1.40 B $ -9.81 M -0.7%
Mar-11 $ 1.46 B $ 1.43 B $ -24.24 M -1.66%
Dec-10 $ 1.35 B $ 1.35 B $ 2.87 M 0.21%
Sep-10 $ 1.24 B $ 1.27 B $ 31.83 M 2.57%
Jun-10 $ 1.26 B $ 1.25 B $ -16.85 M -1.33%
M = millions, B = billions.
Differences are rounded.
Some one-time items are often excluded in reported EPS.

Reported earnings per share compared to the mean estimate. Differences are rounded.

Amgen, Inc. (NASDAQ:AMGN) is expected to report earnings for last fiscal quarter after the closing bell on October 24, 2011.

Overview
AMGN trades an average of 5.4 million shares per day.

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company was founded in 1980 and is headquartered in Thousand Oaks, California.

52-Week High: $61.53
52-Week Low: $47.66
Book Value: $27.72
Float Short: 2.14%

On average, analysts are expecting a drop of $-0.08 in earnings per share compared to last quarter's results of $1.37. The number to beat is $1.29 per share, based on the estimated mean earnings.

The current trailing twelve months (ttm) P/E ratio is 11.7. The forward P/E ratio is 11.2. The stock has moved higher in price 1.38% in the last month, and moving in price 4.79% from one year ago. The stock has done well as compared to the overall market. When comparing to the S&P 500, the year-to-date difference is 7.55%.

The company has rising revenue year-over-year of $15.05 billion for 2010 vs. $14.64 billion for 2009. The bottom line has rising earnings year-over-year of $4.63 billion for 2010 vs. $4.61 billion for 2009. The company's earnings before income and taxes are rising, with an EBIT year-over-year of $5.55 billion for 2010 vs. $5.51 billion for 2009.

paid2trade.com revenue gross bar chart for AMGN

Gross reported revenue compared to the mean estimate (rounded).

Fiscal Quarter Ending Month-Year Revenue Estimates Actual $ Difference Difference %
Jun-11 $ 3.78 B $ 3.96 B $ 182.10 M 4.82%
Mar-11 $ 3.69 B $ 3.71 B $ 20.33 M 0.55%
Dec-10 $ 3.81 B $ 3.84 B $ 34.98 M 0.92%
Sep-10 $ 3.77 B $ 3.82 B $ 46.76 M 1.24%
Jun-10 $ 3.71 B $ 3.80 B $ 93.10 M 2.51%
M = millions, B = billions.
Differences are rounded.
Some one-time items are often excluded in reported EPS.

Reported earnings per share compared to the mean estimate. Differences are rounded.

I use a proprietary blend of technical analysis, financial crowd behavior, and fundamentals in my short-term trades, and while not totally the same in longer swing trades to investments, the concepts used are similar. You may want to use this article as a starting point of your own research with your financial planner. I use Seeking Alpha, Edgar Online, and Yahoo Finance for most of my data. I use the confirmed symbols from earnings.com that I believe to be of the most interest.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Source: Earnings Preview: Health Management Associates, Amgen Report Results Monday

Check out Seeking Alpha’s new Earnings Center »